Annual CFF
$6.56 M
+$2.23 M+51.67%
December 31, 2023
Summary
- As of February 8, 2025, MBOT annual cash flow from financing activities is $6.56 million, with the most recent change of +$2.23 million (+51.67%) on December 31, 2023.
- During the last 3 years, MBOT annual CFF has risen by +$9.93 million (+294.31%).
- MBOT annual CFF is now -83.61% below its all-time high of $40.00 million, reached on December 31, 2004.
Performance
MBOT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$633.00 K
-$1.44 M-69.48%
September 30, 2024
Summary
- As of February 8, 2025, MBOT quarterly cash flow from financing activities is $633.00 thousand, with the most recent change of -$1.44 million (-69.48%) on September 30, 2024.
- Over the past year, MBOT quarterly CFF has increased by +$633.00 thousand (+100.00%).
- MBOT quarterly CFF is now -98.12% below its all-time high of $33.61 million, reached on June 30, 2006.
Performance
MBOT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$5.10 M
+$794.00 K+18.42%
September 30, 2024
Summary
- As of February 8, 2025, MBOT TTM cash flow from financing activities is $5.10 million, with the most recent change of +$794.00 thousand (+18.42%) on September 30, 2024.
- Over the past year, MBOT TTM CFF has dropped by -$1.45 million (-22.17%).
- MBOT TTM CFF is now -87.89% below its all-time high of $42.15 million, reached on June 30, 2015.
Performance
MBOT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MBOT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.7% | +100.0% | -22.2% |
| 3 y3 years | +294.3% | +100.0% | -22.2% |
| 5 y5 years | +10000.0% | +100.0% | -22.2% |
MBOT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -90.6% | +493.2% | -53.8% | -100.0% |
| 5 y | 5-year | -82.2% | +294.3% | -97.7% | +118.8% | -86.1% | +251.2% |
| alltime | all time | -83.6% | +294.3% | -98.1% | +103.1% | -87.9% | +124.7% |
Microbot Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $633.00 K(-69.5%) | $5.10 M(+18.4%) |
| Jun 2024 | - | $2.07 M(-13.5%) | $4.31 M(-51.9%) |
| Mar 2024 | - | $2.40 M(>+9900.0%) | $8.96 M(+36.6%) |
| Dec 2023 | $6.56 M(+51.7%) | $0.00(-100.0%) | $6.56 M(-39.7%) |
| Sep 2023 | - | -$161.00 K(-102.4%) | $10.88 M(-1.5%) |
| Jun 2023 | - | $6.72 M(>+9900.0%) | $11.04 M(+155.4%) |
| Mar 2023 | - | $0.00(-100.0%) | $4.32 M(0.0%) |
| Dec 2022 | $4.32 M(>+9900.0%) | $4.32 M(>+9900.0%) | $4.32 M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | $0.00(-100.0%) | - | - |
| Dec 2020 | -$3.38 M(-109.2%) | $0.00(0.0%) | -$3.38 M(-114.2%) |
| Sep 2020 | - | $0.00(0.0%) | $23.83 M(0.0%) |
| Jun 2020 | - | $0.00(-100.0%) | $23.83 M(0.0%) |
| Mar 2020 | - | -$3.38 M(-112.4%) | $23.83 M(-35.2%) |
| Dec 2019 | $36.77 M(<-9900.0%) | $27.21 M(>+9900.0%) | $36.77 M(+285.3%) |
| Sep 2019 | - | $0.00(0.0%) | $9.54 M(0.0%) |
| Jun 2019 | - | $0.00(-100.0%) | $9.54 M(0.0%) |
| Mar 2019 | - | $9.56 M(<-9900.0%) | $9.54 M(<-9900.0%) |
| Dec 2018 | -$18.00 K(-100.1%) | -$18.00 K(<-9900.0%) | -$18.00 K(-104.5%) |
| Sep 2018 | - | $0.00(0.0%) | $397.00 K(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $397.00 K(-96.0%) |
| Mar 2018 | - | $0.00(-100.0%) | $9.94 M(-23.7%) |
| Dec 2017 | $13.02 M(+322.3%) | $397.00 K(>+9900.0%) | $13.02 M(-12.0%) |
| Sep 2017 | - | $0.00(-100.0%) | $14.80 M(-1.0%) |
| Jun 2017 | - | $9.54 M(+209.5%) | $14.96 M(+142.6%) |
| Mar 2017 | - | $3.08 M(+41.4%) | $6.17 M(+100.0%) |
| Dec 2016 | $3.08 M(+646.5%) | $2.18 M(+1314.9%) | $3.08 M(-115.8%) |
| Sep 2016 | - | $154.00 K(-79.5%) | -$19.49 M(-5.8%) |
| Jun 2016 | - | $750.00 K(>+9900.0%) | -$20.68 M(-1022.2%) |
| Mar 2016 | - | $0.00(-100.0%) | $2.24 M(+443.1%) |
| Dec 2015 | $413.00 K(-98.1%) | -$20.39 M(+1851.1%) | $413.00 K(-97.9%) |
| Sep 2015 | - | -$1.04 M(-104.4%) | $19.81 M(-53.0%) |
| Jun 2015 | - | $23.68 M(-1393.9%) | $42.15 M(+137.4%) |
| Mar 2015 | - | -$1.83 M(+83.9%) | $17.75 M(-20.0%) |
| Dec 2014 | $22.20 M(-39.0%) | -$995.30 K(-104.7%) | $22.20 M(-44.5%) |
| Sep 2014 | - | $21.29 M(-3069.4%) | $39.96 M(+69.5%) |
| Jun 2014 | - | -$717.10 K(-127.4%) | $23.58 M(-36.8%) |
| Mar 2014 | - | $2.62 M(-84.4%) | $37.30 M(+2.5%) |
| Dec 2013 | $36.40 M(+41.4%) | $16.77 M(+241.5%) | $36.40 M(+44.2%) |
| Sep 2013 | - | $4.91 M(-62.2%) | $25.24 M(-32.5%) |
| Jun 2013 | - | $13.01 M(+658.2%) | $37.41 M(+39.6%) |
| Mar 2013 | - | $1.72 M(-69.4%) | $26.80 M(+4.1%) |
| Dec 2012 | $25.74 M(+34.5%) | $5.61 M(-67.2%) | $25.74 M(-12.5%) |
| Sep 2012 | - | $17.08 M(+610.7%) | $29.41 M(+123.3%) |
| Jun 2012 | - | $2.40 M(+269.2%) | $13.17 M(+23.8%) |
| Mar 2012 | - | $650.90 K(-93.0%) | $10.64 M(-44.4%) |
| Dec 2011 | $19.13 M(+190.4%) | $9.28 M(+1008.3%) | $19.13 M(+90.2%) |
| Sep 2011 | - | $837.10 K(-752.5%) | $10.06 M(+9.8%) |
| Jun 2011 | - | -$128.30 K(-101.4%) | $9.16 M(-39.4%) |
| Mar 2011 | - | $9.14 M(+4332.0%) | $15.10 M(+129.3%) |
| Dec 2010 | $6.59 M(-77.9%) | $206.30 K(-424.4%) | $6.59 M(-63.9%) |
| Sep 2010 | - | -$63.60 K(-101.1%) | $18.23 M(-13.3%) |
| Jun 2010 | - | $5.82 M(+828.9%) | $21.02 M(-10.7%) |
| Mar 2010 | - | $626.30 K(-94.7%) | $23.54 M(-21.0%) |
| Dec 2009 | $29.79 M(+58.4%) | $11.85 M(+334.4%) | $29.79 M(-18.5%) |
| Sep 2009 | - | $2.73 M(-67.3%) | $36.53 M(+7.6%) |
| Jun 2009 | - | $8.33 M(+21.2%) | $33.96 M(+32.1%) |
| Mar 2009 | - | $6.88 M(-63.0%) | $25.71 M(+36.8%) |
| Dec 2008 | $18.80 M | $18.60 M(>+9900.0%) | $18.80 M(+1190.3%) |
| Sep 2008 | - | $154.60 K(+78.9%) | $1.46 M(+16.3%) |
| Jun 2008 | - | $86.40 K(-334.8%) | $1.25 M(-72.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$36.80 K(-102.9%) | $4.51 M(-24.5%) |
| Dec 2007 | $5.98 M(-82.8%) | $1.25 M(-2641.4%) | $5.98 M(+17.6%) |
| Sep 2007 | - | -$49.30 K(-101.5%) | $5.08 M(+1.4%) |
| Jun 2007 | - | $3.35 M(+134.6%) | $5.01 M(-85.8%) |
| Mar 2007 | - | $1.43 M(+296.1%) | $35.27 M(+1.8%) |
| Dec 2006 | $34.66 M(+459.0%) | $360.10 K(-403.1%) | $34.66 M(-5.4%) |
| Sep 2006 | - | -$118.80 K(-100.4%) | $36.62 M(-4.9%) |
| Jun 2006 | - | $33.61 M(+4050.8%) | $38.51 M(+495.7%) |
| Mar 2006 | - | $809.60 K(-65.2%) | $6.46 M(+4.3%) |
| Dec 2005 | $6.20 M(-84.5%) | $2.32 M(+31.0%) | $6.20 M(-75.6%) |
| Sep 2005 | - | $1.77 M(+13.9%) | $25.39 M(+8.0%) |
| Jun 2005 | - | $1.56 M(+186.1%) | $23.51 M(-42.1%) |
| Mar 2005 | - | $544.30 K(-97.5%) | $40.61 M(+1.5%) |
| Dec 2004 | $40.00 M(+127.6%) | $21.52 M(<-9900.0%) | $40.00 M(+36.1%) |
| Sep 2004 | - | -$107.50 K(-100.6%) | $29.39 M(-0.2%) |
| Jun 2004 | - | $18.66 M(<-9900.0%) | $29.46 M(+68.2%) |
| Mar 2004 | - | -$67.40 K(-100.6%) | $17.51 M(-0.4%) |
| Dec 2003 | $17.58 M(+1971.0%) | $10.91 M(<-9900.0%) | $17.58 M(+162.8%) |
| Sep 2003 | - | -$35.30 K(-100.5%) | $6.69 M(-13.7%) |
| Jun 2003 | - | $6.71 M(<-9900.0%) | $7.75 M(+724.0%) |
| Mar 2003 | - | -$2600.00(-113.8%) | $940.60 K(+10.8%) |
| Dec 2002 | $848.80 K(-91.8%) | $18.90 K(-98.2%) | $848.90 K(-84.4%) |
| Sep 2002 | - | $1.03 M(-1102.6%) | $5.45 M(-39.0%) |
| Jun 2002 | - | -$102.40 K(+8.6%) | $8.93 M(-13.9%) |
| Mar 2002 | - | -$94.30 K(-102.0%) | $10.37 M(-0.4%) |
| Dec 2001 | $10.41 M(+43.8%) | $4.62 M(+2.4%) | $10.41 M(+61.4%) |
| Sep 2001 | - | $4.51 M(+238.0%) | $6.45 M(-5.3%) |
| Jun 2001 | - | $1.33 M(-2486.8%) | $6.81 M(-1.5%) |
| Mar 2001 | - | -$55.90 K(-108.5%) | $6.91 M(-4.5%) |
| Dec 2000 | $7.24 M(-727.4%) | $661.20 K(-86.4%) | $7.24 M(+9.3%) |
| Sep 2000 | - | $4.87 M(+238.8%) | $6.62 M(+427.5%) |
| Jun 2000 | - | $1.44 M(+426.9%) | $1.26 M(-316.1%) |
| Mar 2000 | - | $272.60 K(+486.2%) | -$580.90 K(-49.6%) |
| Dec 1999 | -$1.15 M(-1253.5%) | $46.50 K(-109.3%) | -$1.15 M(-23.1%) |
| Sep 1999 | - | -$500.00 K(+25.0%) | -$1.50 M(-11.8%) |
| Jun 1999 | - | -$400.00 K(+33.3%) | -$1.70 M(+1600.0%) |
| Mar 1999 | - | -$300.00 K(0.0%) | -$100.00 K(-200.0%) |
| Dec 1998 | $100.00 K(-133.3%) | -$300.00 K(-57.1%) | $100.00 K(-66.7%) |
| Sep 1998 | - | -$700.00 K(-158.3%) | $300.00 K(-70.0%) |
| Jun 1998 | - | $1.20 M(-1300.0%) | $1.00 M(-350.0%) |
| Mar 1998 | - | -$100.00 K(0.0%) | -$400.00 K(+33.3%) |
| Dec 1997 | -$300.00 K(-102.2%) | -$100.00 K(<-9900.0%) | -$300.00 K(-102.9%) |
| Sep 1997 | - | $0.00(-100.0%) | $10.30 M(-15.6%) |
| Jun 1997 | - | -$200.00 K(<-9900.0%) | $12.20 M(-7.6%) |
| Mar 1997 | - | $0.00(-100.0%) | $13.20 M(-4.3%) |
| Dec 1996 | $13.80 M(-55.8%) | $10.50 M(+452.6%) | $13.80 M(-44.1%) |
| Sep 1996 | - | $1.90 M(+137.5%) | $24.70 M(+7.4%) |
| Jun 1996 | - | $800.00 K(+33.3%) | $23.00 M(-28.1%) |
| Mar 1996 | - | $600.00 K(-97.2%) | $32.00 M(+2.6%) |
| Dec 1995 | $31.20 M(+365.7%) | $21.40 M(>+9900.0%) | $31.20 M(+162.2%) |
| Sep 1995 | - | $200.00 K(-98.0%) | $11.90 M(-2.5%) |
| Jun 1995 | - | $9.80 M(-5000.0%) | $12.20 M(+84.8%) |
| Mar 1995 | - | -$200.00 K(-109.5%) | $6.60 M(-1.5%) |
| Dec 1994 | $6.70 M(-61.0%) | $2.10 M(+320.0%) | $6.70 M(+45.7%) |
| Sep 1994 | - | $500.00 K(-88.1%) | $4.60 M(+12.2%) |
| Jun 1994 | - | $4.20 M(-4300.0%) | $4.10 M(-2150.0%) |
| Mar 1994 | - | -$100.00 K(0.0%) | -$200.00 K(0.0%) |
| Dec 1993 | $17.20 M(-36.5%) | - | - |
| Jun 1993 | - | -$100.00 K(0.0%) | -$200.00 K(+100.0%) |
| Mar 1993 | - | -$100.00 K | -$100.00 K |
| Dec 1992 | $27.10 M(+77.1%) | - | - |
| Dec 1991 | $15.30 M | - | - |
FAQ
- What is Microbot Medical annual cash flow from financing activities?
- What is the all time high annual CFF for Microbot Medical?
- What is Microbot Medical annual CFF year-on-year change?
- What is Microbot Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Microbot Medical?
- What is Microbot Medical quarterly CFF year-on-year change?
- What is Microbot Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Microbot Medical?
- What is Microbot Medical TTM CFF year-on-year change?
What is Microbot Medical annual cash flow from financing activities?
The current annual CFF of MBOT is $6.56 M
What is the all time high annual CFF for Microbot Medical?
Microbot Medical all-time high annual cash flow from financing activities is $40.00 M
What is Microbot Medical annual CFF year-on-year change?
Over the past year, MBOT annual cash flow from financing activities has changed by +$2.23 M (+51.67%)
What is Microbot Medical quarterly cash flow from financing activities?
The current quarterly CFF of MBOT is $633.00 K
What is the all time high quarterly CFF for Microbot Medical?
Microbot Medical all-time high quarterly cash flow from financing activities is $33.61 M
What is Microbot Medical quarterly CFF year-on-year change?
Over the past year, MBOT quarterly cash flow from financing activities has changed by +$633.00 K (+100.00%)
What is Microbot Medical TTM cash flow from financing activities?
The current TTM CFF of MBOT is $5.10 M
What is the all time high TTM CFF for Microbot Medical?
Microbot Medical all-time high TTM cash flow from financing activities is $42.15 M
What is Microbot Medical TTM CFF year-on-year change?
Over the past year, MBOT TTM cash flow from financing activities has changed by -$1.45 M (-22.17%)